• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 10 of 10 Results
Document Number CR260306
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE TDM Acetaminophen Gen.2} 
CR260306 K141928 Acetaminophen Toxicology / TDM MODERATE 05/06/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE TDM Amikacin} 
CR260306 K032279 Amikacin Toxicology / TDM MODERATE 05/06/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE TDM Carbamazepine Gen.4} 
CR260306 K151578 Carbamazepine Toxicology / TDM MODERATE 05/06/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE TDM Digoxin} 
CR260306 K961824 Digoxin Toxicology / TDM MODERATE 05/06/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE TDM Methotrexate} 
CR260306 K233454 Methotrexate Toxicology / TDM MODERATE 05/06/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE TDM Phenobarbital} 
CR260306 K071644 Phenobarbital Toxicology / TDM MODERATE 05/06/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE TDM Phenytoin} 
CR260306 K030428 Phenytoin Toxicology / TDM MODERATE 05/06/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE TDM Theophylline} 
CR260306 K020740 Theophylline Toxicology / TDM MODERATE 05/06/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE TDM Tobramycin} 
CR260306 K060853 Tobramycin Toxicology / TDM MODERATE 05/06/2026
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE TDM Vancomycin Gen.3} 
CR260306 K152245 Vancomycin Toxicology / TDM MODERATE 05/06/2026

-
-